May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Detection of Circulating Endothelial Precursor Cells by in vivo Flow Cytometry
Author Affiliations & Notes
  • J.M. Runnels
    Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA
  • M. Poureshagh
    Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA
  • J. Novak
    Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA
  • P. D'Amore
    Schepens Eye Research Institute, Boston, MA
  • C.P. Lin
    Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA
  • Footnotes
    Commercial Relationships  J.M. Runnels, None; M. Poureshagh, None; J. Novak, None; P. D'Amore, None; C.P. Lin, None.
  • Footnotes
    Support  NIH Grant EY14106, EB000664
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 3229. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J.M. Runnels, M. Poureshagh, J. Novak, P. D'Amore, C.P. Lin; Detection of Circulating Endothelial Precursor Cells by in vivo Flow Cytometry . Invest. Ophthalmol. Vis. Sci. 2005;46(13):3229.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: : Angiogenesis and its consequences are devastating in diseases such as proliferative diabetic retinopathy and age related macular degeneration. Postnatal angiogenesis involves release of endothelial precursor cells (EPC) from the stem cell reservoir of bone marrow into the circulation. Like mature endothelial cells which are incorporated into the vasculature, EPC express endothelial–specific receptor tyrosine kinase (Tek or Tie2), but unlike mature endothelial cells, they can be found in the circulation for a limited time. Using FACS analyses of multiple blood samples, EPC have been identified and followed in organisms undergoing angiogenesis. We set out to develop a method to noninvasively identify these cells directly within the circulation of live mice. Methods:Circulating EPC were detected and counted using an in vivo flow cytometer developed in this laboratory. This method offers the advantage of following cell populations over time within an individual without repeated blood sampling. Like FACS analysis, in vivo flow cytometry makes use of laser illumination of a narrow stream of moving cells; specifically, cells circulating through an arteriole. Mice that express green fluorescent protein (GFP) under the control of the Tie2 gene were used to measure bone marrow derived EPC in the circulation before and after intravenous injection of recombinant mouse VEGF (vascular endothelial growth factor). VEGF is a potent angiogenic factor, which has been shown to mobilize VEGFR2, Tie2 positive EPC from the bone marrow. Results: No GFP positive cells were detected in the circulation before VEGF injection. Tie2–GFP positive cells became apparent 40 minutes after a single injection of 1 ug VEGF, and persisted for up to 2 hrs. The peak cell count was about 5 cells/min in a 30 micron arteriole, corresponding to approximately 50,000 cells per ml of blood. Conclusions: In vivo flow cytometry can be used to detect circulating EPC when they are responding to a limited VEGF signal. The response to VEGF was rapid and short–lived. This method may be useful in the study of many conditions in which postnatal angiogenesis is a factor as in conditions involving retinal neovascularization.

Keywords: vascular cells • imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) • flow cytometry 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×